SIRONA CAPITAL
Sirona Capital is a real estate firm that focusses on property investment, development, and urban renewal.
Similar Organizations
AG Capital
AG Capital is an investment firm that provides investment and property management solutions for middle-size businesses.
Arden Group
Arden Group is a privately held, vertically-integrated real estate fund manager, investor, and operator.
RW Capital Partners
RW Capital Partners is a real estate private equity firm focused on the acquisition and re-development of commercial properties.
Current Employees Featured
Kelvin Flynn Founder @ Sirona Capital
Founder
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-15 | Fuse Biotherapeutics | Sirona Capital investment in Seed Round - Fuse Biotherapeutics | 9.5 M USD |
| 2021-11-02 | Antiva Biosciences | Sirona Capital investment in Series D - Antiva Biosciences | 31 M USD |
| 2021-09-08 | ADARx Pharmaceuticals | Sirona Capital investment in Series B - ADARx Pharmaceuticals | 75 M USD |
| 2018-07-10 | Antiva Biosciences | Sirona Capital investment in Series C - Antiva Biosciences | 15 M USD |
| 2018-04-09 | Constellation Pharmaceuticals | Sirona Capital investment in Series F - Constellation Pharmaceuticals | 100 M USD |
| 2018-04-04 | Arvinas | Sirona Capital investment in Series C - Arvinas | 55 M USD |
| 2018-03-21 | TCR2 | Sirona Capital investment in Series B - TCR2 | 125 M USD |
| 2018-02-28 | Viela Bio | Sirona Capital investment in Series A - Viela Bio | 282.25 M USD |
| 2017-12-11 | Hookipa Pharma | Sirona Capital investment in Series C - Hookipa Pharma | 60 M USD |
| 2017-11-29 | Codiak Biosciences | Sirona Capital investment in Series C - Codiak Biosciences | 76.5 M USD |
More informations about "Sirona Capital"
Sirona Capital - Crunchbase Investor Profile
Sirona Capital invests in early to late-stage biotechnology and healthcare companies, focusing on the United States, particularly in California and Massachusetts.See details»
Sirona Capital - LinkedIn
Sirona Capital invests in the future of healthcare innovation and therapeutics. As a dedicated healthcare venture capital fund, we are committed to identifying and supporting visionary ...See details»
Sirona Capital - Investments, Portfolio & Company Exits
Sirona Capital has made 14 investments. Their most recent investment was on Dec 14, 2023, when Synnovation Therapeutics raisedSee details»
Sirona Capital Global Fund: Performance | PitchBook
General Information Description Sirona Capital Global Fund is a venture capital fund managed by Sirona Capital. The fund is located in George Town, Cayman Islands. The fund targets …See details»
Portfolio - Sirona Capital -Sirona Capital
Sirona Capital PortfolioSee details»
Sirona Capital investment portfolio | PitchBook
Founded in 2021, Sirona Capital is a venture capital firm based in George Town, Cayman Islands.See details»
Sirona Capital - Investor Profile, Portfolio & Team - Tracxn
Jan 29, 2025 Sirona Capital - Venture Capital firm investing in healthcare innovation and therapeutics. Portfolio of 11 companies. 29 investors have invested with Sirona Capital. Team …See details»
News - Sirona Capital
Jan 24, 2024 Latest news CG Oncology Follows Big IPO With New Results For Bladder Cancer Drug BioPharma Dive May 03 2024 CG Oncology Announces First Patient Dosed in PIVOT …See details»
SIRONA CAPITAL
Sirona Capital ist ein führender Investment- und Entwicklungsmanager, der sich auf Immobilien und Infrastrukturprojekte spezialisiert hat.See details»
Sirona Capital - Funding, Financials, Valuation & Investors
Sirona Capital has raised a single venture fund, Sirona Capital Global Fund.See details»
Sirona Capital | Institution Profile | Private Equity International
Use Private Equity International's platform to access the latest news, analysis, insights and fund data for Sirona Capital, as well as key contact information.See details»
Sirona Capital secures $190m - Green Street News
PERTH’S Sirona Capital has secured a $190 million funding package from First State Super for the Kings Square Fremantle redevelopment. First State Super chief investment officer Damian …See details»
Sirona Capital Portfolio Investments, Sirona Capital Funds, Sirona ...
Jan 20, 2023 Sirona Capital is a specialist alternative funds manager with a focus on urban renewal, private real estate and agriculture. Use the CB Insights Platform to explore Sirona …See details»
Sirona Capital - Overview, News & Similar companies - ZoomInfo
Nov 15, 2022 Sirona Capital consults to a number of major global private equity funds, investment banks and institutional investors, in relation to identifying and evaluating …See details»
Sirona Capital - Updates, News, Events, Signals & Triggers
Sirona Capital invests in early to late-stage biotechnology and healthcare companies, focusing on the United States, particularly in California and Massachusetts.See details»
Synnovation Therapeutics - Sirona CapitalSirona Capital
Status: Private Synnovation is a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against highly validated disease targets. …See details»
Sirona Capital – Investors Database – Unicorn Nest
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our …See details»
Eric Trump announces lawsuit against Capital One over alleged de ...
Mar 7, 2025 The Trump Organization is suing Capital One for de-banking its accounts in 2021, according to Eric Trump. The lawsuit was filed in Miami-Dade Circuit Court and claimed that …See details»
Trump Organization accuses ‘woke’ Capital One of de-banking
Mar 10, 2025 Trump Organization accuses ‘woke’ Capital One of de-banking The lender de-banked some 300 Trump Organization accounts because it believed “the political tide at the …See details»
Arvinas - Sirona CapitalSirona Capital
Status: IPO (NASDAQ: ARVN) Arvinas is singularly focused on developing new options for patients in need, pioneering a new class of medicines to target and degrade disease-related …See details»